"With Lilly able to adequately supply current and future demand for tirzepatide, we believe it could continue to grow market share in incretin products as manufacturing continues to expand," BMO Capital Markets senior research analyst Evan Seigerman wrote in a note to clients
A reliable starting point to breaking through a semaglutide weight loss plateau is getting a handle on your caloric intake (if you havent already) and then cutting back a bit
The goal is not to create a large or complicated supplement stack
Some compounding pharmacies offer it anyway, operating under the rationale that: It's prescribed by a licensed provider for a specific patient (503A pathway) The compound is not explicitly prohibited (no FDA warning letter or enforcement action yet) State pharmacy boards have not prohibited it What could change: If the FDA decides compounding of investigational drugs violates federal law, they could issue warning letters to pharmacies offering compounded retatrutide
And so, while those basic-science lab studies and animal studies are promising, before we can really see if the hope matches the hype, weve got to see some additional research. Spittler agreed